[HTML][HTML] Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - Molecular cancer, 2017 - Springer
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
[引用][C] Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - Molecular Cancer, 2017 - cir.nii.ac.jp
Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - Molecular cancer, 2017 - pubmed.ncbi.nlm.nih.gov
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - Molecular Cancer, 2017 - go.gale.com
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
[HTML][HTML] Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - Molecular Cancer, 2017 - molecular-cancer.biomedcentral …
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
Tumor-related interleukins: old validated targets for new anti-cancer drug development.
S Setrerrahmane, H Xu - Molecular Cancer, 2017 - search.ebscohost.com
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - Molecular Cancer, 2017 - search.proquest.com
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
Tumor-related interleukins: old validated targets for new anti-cancer drug development.
S Setrerrahmane, H Xu - Molecular Cancer, 2017 - europepmc.org
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
[HTML][HTML] Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - Molecular Cancer, 2017 - ncbi.nlm.nih.gov
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …
[PDF][PDF] Tumor-related interleukins: old validated targets for new anti-cancer drug development
S Setrerrahmane, H Xu - 2017 - molecular-cancer.biomedcentral …
In-depth knowledge of cancer molecular and cellular mechanisms have revealed a strong
regulation of cancer development and progression by the inflammation which orchestrates …
regulation of cancer development and progression by the inflammation which orchestrates …